Recombinant DNA Technology Market Report

China Recombinant DNA Technology Industry Market Research Report 2023-2029

  • POSTDATE：Oct 10, 2023
  • PAGES：143
  • REPORT CODE：GMM1841926
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Recombinant DNA Technology industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Merck KGaA

    • GlaxoSmithKline

    • New England Biolabs

    • Pfizer Inc

    • Biogen

    • Sanofi

    • Cibus

    • Eli Lilly and Company

    • Monsanto Company

    • Profacgen

    • Amgen

    • GenScript

    • Roche

    • Novartis

    By Type:

    • Vaccine

    • Biotech Crops

    • Specialty Chemicals

    • Therapeutic Agent

    By Application:

    • Biotechnology and Pharmaceutical Companies

    • Academic & Government Research Institutes

    • Others

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Recombinant DNA Technology Market Overview 2018-2029

    • 1.1 China Recombinant DNA Technology Industry Development Overview

    • 1.2 China Recombinant DNA Technology Industry Development History

    • 1.3 China Recombinant DNA Technology Industry Market Size (2018-2029)

    • 1.4 China Recombinant DNA Technology Market Analysis by Type from Production Side

      • 1.4.1 China Recombinant DNA Technology Production Volume, Production Value and Growth Rate of Vaccine (2018-2029)

      • 1.4.2 China Recombinant DNA Technology Production Volume, Production Value and Growth Rate of Biotech Crops (2018-2029)

      • 1.4.3 China Recombinant DNA Technology Production Volume, Production Value and Growth Rate of Specialty Chemicals (2018-2029)

      • 1.4.4 China Recombinant DNA Technology Production Volume, Production Value and Growth Rate of Therapeutic Agent (2018-2029)

    • 1.5 China Recombinant DNA Technology Market Analysis by Application from Consumption End

      • 1.5.1 China Recombinant DNA Technology Sales Volume, Sales Value and Growth Rate of Biotechnology and Pharmaceutical Companies (2018-2029)

      • 1.5.2 China Recombinant DNA Technology Sales Volume, Sales Value and Growth Rate of Academic & Government Research Institutes (2018-2029)

      • 1.5.3 China Recombinant DNA Technology Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • 1.6 China Recombinant DNA Technology Market Analysis by Region

      • 1.6.1 North China Recombinant DNA Technology Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Recombinant DNA Technology Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Recombinant DNA Technology Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Recombinant DNA Technology Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Recombinant DNA Technology Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Recombinant DNA Technology Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Recombinant DNA Technology Market Size and Growth Rate from 2018-2029

    Chapter 2 China Recombinant DNA Technology Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Recombinant DNA Technology Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Recombinant DNA Technology Market Status and Competition Analysis in 2023

      • 2.2.3 China Recombinant DNA Technology Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Recombinant DNA Technology Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Recombinant DNA Technology Industry Development

    Chapter 3 Recombinant DNA TechnologyIndustry Chain Analysis

    • 3.1 Recombinant DNA Technology Industry Chain

    • 3.2 Recombinant DNA Technology Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Recombinant DNA Technology Market

    • 3.3 Recombinant DNA Technology Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Recombinant DNA Technology Market

    Chapter 4 China Recombinant DNA Technology Market, by Type

    • 4.1 China Recombinant DNA Technology Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Recombinant DNA Technology Total Production Volume and Growth Rate from Production Side

    • 4.5 China Recombinant DNA Technology Production Volume and Growth Rate, by Type

      • 4.5.1 China Recombinant DNA Technology Production Volume and Growth Rate of Vaccine

      • 4.5.2 China Recombinant DNA Technology Production Volume and Growth Rate of Biotech Crops

      • 4.5.3 China Recombinant DNA Technology Production Volume and Growth Rate of Specialty Chemicals

      • 4.5.4 China Recombinant DNA Technology Production Volume and Growth Rate of Therapeutic Agent

    Chapter 5 China Recombinant DNA Technology Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Recombinant DNA Technology Total Market Size and Growth Rate from Consumption End

    • 5.5 China Recombinant DNA Technology Market Size and Growth Rate, by Application

      • 5.5.1 China Recombinant DNA Technology Market Size and Growth Rate of Biotechnology and Pharmaceutical Companies

      • 5.5.2 China Recombinant DNA Technology Market Size and Growth Rate of Academic & Government Research Institutes

      • 5.5.3 China Recombinant DNA Technology Market Size and Growth Rate of Others

    Chapter 6 China Recombinant DNA Technology Market, by Region

    • 6.1 China Recombinant DNA Technology Production Volume and Production Value, by Region

    • 6.2 China Recombinant DNA Technology Sales Volume and Sales Value, by Region

    Chapter 7 North China Recombinant DNA Technology Market Analysis

    • 7.1 North China Recombinant DNA Technology Market, by Type

    • 7.2 North China Recombinant DNA Technology Market, by Application

    Chapter 8 Central China Recombinant DNA Technology Market Analysis

    • 8.1 Central China Recombinant DNA Technology Market, by Type

    • 8.2 Central China Recombinant DNA Technology Market, by Application

    Chapter 9 South China Recombinant DNA Technology Market Analysis

    • 9.1 South China Recombinant DNA Technology Market, by Type

    • 9.2 South China Recombinant DNA Technology Market, by Application

    Chapter 10 East China Recombinant DNA Technology Market Analysis

    • 10.1 East China Recombinant DNA Technology Market, by Type

    • 10.2 East China Recombinant DNA Technology Market, by Application

    Chapter 11 Northeast China Recombinant DNA Technology Market Analysis

    • 11.1 Northeast China Recombinant DNA Technology Market, by Type

    • 11.2 Northeast China Recombinant DNA Technology Market, by Application

    Chapter 12 Southwest China Recombinant DNA Technology Market Analysis

    • 12.1 Southwest China Recombinant DNA Technology Market, by Type

    • 12.2 Southwest China Recombinant DNA Technology Market, by Application

    Chapter 13 Northwest China Recombinant DNA Technology Market Analysis

    • 13.1 Northwest China Recombinant DNA Technology Market, by Type

    • 13.2 Northwest China Recombinant DNA Technology Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Merck KGaA

        • 14.1.1 Merck KGaA Company Profile

        • 14.1.2 Merck KGaA Recombinant DNA Technology Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 GlaxoSmithKline

        • 14.2.1 GlaxoSmithKline Company Profile

        • 14.2.2 GlaxoSmithKline Recombinant DNA Technology Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 New England Biolabs

        • 14.3.1 New England Biolabs Company Profile

        • 14.3.2 New England Biolabs Recombinant DNA Technology Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Pfizer Inc

        • 14.4.1 Pfizer Inc Company Profile

        • 14.4.2 Pfizer Inc Recombinant DNA Technology Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Biogen

        • 14.5.1 Biogen Company Profile

        • 14.5.2 Biogen Recombinant DNA Technology Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Sanofi

        • 14.6.1 Sanofi Company Profile

        • 14.6.2 Sanofi Recombinant DNA Technology Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Cibus

        • 14.7.1 Cibus Company Profile

        • 14.7.2 Cibus Recombinant DNA Technology Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Eli Lilly and Company

        • 14.8.1 Eli Lilly and Company Company Profile

        • 14.8.2 Eli Lilly and Company Recombinant DNA Technology Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Monsanto Company

        • 14.9.1 Monsanto Company Company Profile

        • 14.9.2 Monsanto Company Recombinant DNA Technology Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Profacgen

        • 14.10.1 Profacgen Company Profile

        • 14.10.2 Profacgen Recombinant DNA Technology Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Amgen

        • 14.11.1 Amgen Company Profile

        • 14.11.2 Amgen Recombinant DNA Technology Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 GenScript

        • 14.12.1 GenScript Company Profile

        • 14.12.2 GenScript Recombinant DNA Technology Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Roche

        • 14.13.1 Roche Company Profile

        • 14.13.2 Roche Recombinant DNA Technology Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Novartis

        • 14.14.1 Novartis Company Profile

        • 14.14.2 Novartis Recombinant DNA Technology Market Performance

        • 14.14.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Recombinant DNA Technology Industry Research Conclusions

    • 15.2 Recombinant DNA Technology Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Recombinant DNA Technology Industry Market Size (2018-2029)

    • Figure China Recombinant DNA Technology Production Volume, Production Value and Growth Rate of Vaccine (2018-2029)

    • Figure China Recombinant DNA Technology Production Volume, Production Value and Growth Rate of Biotech Crops (2018-2029)

    • Figure China Recombinant DNA Technology Production Volume, Production Value and Growth Rate of Specialty Chemicals (2018-2029)

    • Figure China Recombinant DNA Technology Production Volume, Production Value and Growth Rate of Therapeutic Agent (2018-2029)

    • Figure China Recombinant DNA Technology Sales Volume, Sales Value and Growth Rate of Biotechnology and Pharmaceutical Companies (2018-2029)

    • Figure China Recombinant DNA Technology Sales Volume, Sales Value and Growth Rate of Academic & Government Research Institutes (2018-2029)

    • Figure China Recombinant DNA Technology Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure North China Recombinant DNA Technology Market Size and Growth Rate from 2018-2029

    • Figure Central China Recombinant DNA Technology Market Size and Growth Rate from 2018-2029

    • Figure South China Recombinant DNA Technology Market Size and Growth Rate from 2018-2029

    • Figure East China Recombinant DNA Technology Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Recombinant DNA Technology Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Recombinant DNA Technology Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Recombinant DNA Technology Market Size and Growth Rate from 2018-2029

    • Figure Recombinant DNA Technology Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Recombinant DNA Technology Market Share by Type in 2018

    • Figure China Recombinant DNA Technology Market Share by Type in 2023

    • Figure China Recombinant DNA Technology Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Recombinant DNA Technology Production Volume and Growth Rate of Vaccine (2018-2023)

    • Figure China Recombinant DNA Technology Production Volume and Growth Rate of Biotech Crops (2018-2023)

    • Figure China Recombinant DNA Technology Production Volume and Growth Rate of Specialty Chemicals (2018-2023)

    • Figure China Recombinant DNA Technology Production Volume and Growth Rate of Therapeutic Agent (2018-2023)

    • Figure China Recombinant DNA Technology Market Share by Application in 2018

    • Figure China Recombinant DNA Technology Market Share by Application in 2023

    • Figure China Recombinant DNA Technology Total Market Size and Growth Rate from Consumption End

    • Figure China Recombinant DNA Technology Market Size and Growth Rate of Biotechnology and Pharmaceutical Companies (2018-2023)

    • Figure China Recombinant DNA Technology Market Size and Growth Rate of Academic & Government Research Institutes (2018-2023)

    • Figure China Recombinant DNA Technology Market Size and Growth Rate of Others (2018-2023)

    • Table China Recombinant DNA Technology Production Volume by Region (2018-2023)

    • Table China Recombinant DNA Technology Production Volume Share by Region (2018-2023)

    • Figure China Recombinant DNA Technology Production Volume Share by Region (2018-2023)

    • Table China Recombinant DNA Technology Production Value by Region (2018-2023)

    • Table China Recombinant DNA Technology Production Value Share by Region (2018-2023)

    • Figure China Recombinant DNA Technology Production Value Share by Region (2018-2023)

    • Table China Recombinant DNA Technology Sales Volume by Region (2018-2023)

    • Table China Recombinant DNA Technology Sales Volume Share by Region (2018-2023)

    • Figure China Recombinant DNA Technology Sales Volume Share by Region (2018-2023)

    • Table China Recombinant DNA Technology Sales Value by Region (2018-2023)

    • Table China Recombinant DNA Technology Sales Value Share by Region (2018-2023)

    • Figure China Recombinant DNA Technology Sales Value Share by Region (2018-2023)

    • Table North China Recombinant DNA Technology Production Volume by Type (2018-2023)

    • Table North China Recombinant DNA Technology Production Volume Share by Type (2018-2023)

    • Figure North China Recombinant DNA Technology Production Volume Share by Type (2018-2023)

    • Table North China Recombinant DNA Technology Sales Volume by Application (2018-2023)

    • Table North China Recombinant DNA Technology Sales Volume Share by Application (2018-2023)

    • Figure North China Recombinant DNA Technology Sales Volume Share by Application (2018-2023)

    • Table Central China Recombinant DNA Technology Production Volume by Type (2018-2023)

    • Table Central China Recombinant DNA Technology Production Volume Share by Type (2018-2023)

    • Figure Central China Recombinant DNA Technology Production Volume Share by Type (2018-2023)

    • Table Central China Recombinant DNA Technology Sales Volume by Application (2018-2023)

    • Table Central China Recombinant DNA Technology Sales Volume Share by Application (2018-2023)

    • Figure Central China Recombinant DNA Technology Sales Volume Share by Application (2018-2023)

    • Table South China Recombinant DNA Technology Production Volume by Type (2018-2023)

    • Table South China Recombinant DNA Technology Production Volume Share by Type (2018-2023)

    • Figure South China Recombinant DNA Technology Production Volume Share by Type (2018-2023)

    • Table South China Recombinant DNA Technology Sales Volume by Application (2018-2023)

    • Table South China Recombinant DNA Technology Sales Volume Share by Application (2018-2023)

    • Figure South China Recombinant DNA Technology Sales Volume Share by Application (2018-2023)

    • Table East China Recombinant DNA Technology Production Volume by Type (2018-2023)

    • Table East China Recombinant DNA Technology Production Volume Share by Type (2018-2023)

    • Figure East China Recombinant DNA Technology Production Volume Share by Type (2018-2023)

    • Table East China Recombinant DNA Technology Sales Volume by Application (2018-2023)

    • Table East China Recombinant DNA Technology Sales Volume Share by Application (2018-2023)

    • Figure East China Recombinant DNA Technology Sales Volume Share by Application (2018-2023)

    • Table Northeast China Recombinant DNA Technology Production Volume by Type (2018-2023)

    • Table Northeast China Recombinant DNA Technology Production Volume Share by Type (2018-2023)

    • Figure Northeast China Recombinant DNA Technology Production Volume Share by Type (2018-2023)

    • Table Northeast China Recombinant DNA Technology Sales Volume by Application (2018-2023)

    • Table Northeast China Recombinant DNA Technology Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Recombinant DNA Technology Sales Volume Share by Application (2018-2023)

    • Table Southwest China Recombinant DNA Technology Production Volume by Type (2018-2023)

    • Table Southwest China Recombinant DNA Technology Production Volume Share by Type (2018-2023)

    • Figure Southwest China Recombinant DNA Technology Production Volume Share by Type (2018-2023)

    • Table Southwest China Recombinant DNA Technology Sales Volume by Application (2018-2023)

    • Table Southwest China Recombinant DNA Technology Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Recombinant DNA Technology Sales Volume Share by Application (2018-2023)

    • Table Northwest China Recombinant DNA Technology Production Volume by Type (2018-2023)

    • Table Northwest China Recombinant DNA Technology Production Volume Share by Type (2018-2023)

    • Figure Northwest China Recombinant DNA Technology Production Volume Share by Type (2018-2023)

    • Table Northwest China Recombinant DNA Technology Sales Volume by Application (2018-2023)

    • Table Northwest China Recombinant DNA Technology Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Recombinant DNA Technology Sales Volume Share by Application (2018-2023)

    • Table Merck KGaA Company Profile

    • Table Merck KGaA Recombinant DNA Technology Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline Recombinant DNA Technology Revenue, Price and Gross (2018-2023)

    • Table New England Biolabs Company Profile

    • Table New England Biolabs Recombinant DNA Technology Revenue, Price and Gross (2018-2023)

    • Table Pfizer Inc Company Profile

    • Table Pfizer Inc Recombinant DNA Technology Revenue, Price and Gross (2018-2023)

    • Table Biogen Company Profile

    • Table Biogen Recombinant DNA Technology Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Recombinant DNA Technology Revenue, Price and Gross (2018-2023)

    • Table Cibus Company Profile

    • Table Cibus Recombinant DNA Technology Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly and Company Company Profile

    • Table Eli Lilly and Company Recombinant DNA Technology Revenue, Price and Gross (2018-2023)

    • Table Monsanto Company Company Profile

    • Table Monsanto Company Recombinant DNA Technology Revenue, Price and Gross (2018-2023)

    • Table Profacgen Company Profile

    • Table Profacgen Recombinant DNA Technology Revenue, Price and Gross (2018-2023)

    • Table Amgen Company Profile

    • Table Amgen Recombinant DNA Technology Revenue, Price and Gross (2018-2023)

    • Table GenScript Company Profile

    • Table GenScript Recombinant DNA Technology Revenue, Price and Gross (2018-2023)

    • Table Roche Company Profile

    • Table Roche Recombinant DNA Technology Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Recombinant DNA Technology Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US